SMC Research and Development Department is well equipped to enable proper formulation and development of pharmaceutical finished dosage forms.
The accredited laboratory, which is equipped with sophisticated instruments, supports all the development work for new analytical methods and provides supports for formulation and development. In addition, walk-in stability chambers with data logger software help support stability studies in accordance with the PICs guideline.
A number of independent clinical trials, bio-equivalence studies and permeability studies have been conducted to demonstrate the efficacy of SMC products in comparison to the original products.
SMC’s bioequivalence studies have been carried out by various Academic Institutes in Thailand, namely that of Zimmex (Simvastatin), Zensil tablet (Cetirizine HCL), Virogon 800 (acyclovir), Kyrin (fluconazole 200 mg),Tanzaril ( losartan potassium 50 mg ), Glubosil (Pioglitazone 30 mg), Quinsil 20(Accupril) and others.